Related Experiment Video
Updated: May 26, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Statistical approaches for conducting network meta-analysis in drug development.
Byron Jones1, James Roger, Peter W Lane
1Novartis, Basel, Switzerland. byron.jones@novartis.com
Network meta-analysis (NMA) statistically combines direct and indirect evidence for health technology assessment. This guide details NMA methods, including random-effects models and Bayesian approaches, with SAS code examples.
Area of Science:
- Health Technology Assessment
- Evidence Synthesis
- Biostatistics
Background:
- Network meta-analysis (NMA) extends standard meta-analysis by integrating direct and indirect treatment comparisons.
- NMA is crucial for evaluating new health technologies during development and approval processes.
Purpose of the Study:
- To detail statistical approaches for conducting network meta-analysis (NMA).
- To provide practical guidance and SAS code for implementing NMA methods.
- To address overlooked aspects of NMA, such as random-effects constraints.
Main Methods:
- Illustrates NMA using fixed-effects and random-effects models.
- Compares frequentist and Bayesian statistical approaches for NMA.
- Demonstrates NMA with SAS code examples for pharmaceutical industry statisticians.
Main Results:
- Explains NMA as analogous to analyzing incomplete-block designs.
- Highlights the impact of random-effects constraints on NMA estimates and standard errors.
- Proposes symmetric constraints for random effects in NMA.
Conclusions:
- Emphasizes the role of statisticians in planning and executing NMAs.
- Discusses strategies for managing heterogeneity in NMA.
- Provides a comprehensive overview of NMA for health technology assessment.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Measurement of Bioavailability: Pharmacodynamic Methods
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...